These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6244309)
21. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702. Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411 [TBL] [Abstract][Full Text] [Related]
22. Suppression of Ca2+ oscillations induced by cholecystokinin (CCK) and its analog OPE in rat pancreatic acinar cells by low-level protein kinase C activation without transition of the CCK receptor from a high- to low-affinity state. Gaisano HY; Miller LJ; Foskett JK Pflugers Arch; 1994 Jul; 427(5-6):455-62. PubMed ID: 7971144 [TBL] [Abstract][Full Text] [Related]
23. The regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini. Tsunoda Y; Owyang C Biochem Biophys Res Commun; 1995 Jun; 211(2):648-55. PubMed ID: 7540841 [TBL] [Abstract][Full Text] [Related]
25. Properties of receptors for gastrin and CCK on gastric smooth muscle cells. Menozzi D; Gardner JD; Jensen RT; Maton PN Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654 [TBL] [Abstract][Full Text] [Related]
26. A role for the p38 mitogen-activated protein kinase/Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini. Schäfer C; Ross SE; Bragado MJ; Groblewski GE; Ernst SA; Williams JA J Biol Chem; 1998 Sep; 273(37):24173-80. PubMed ID: 9727040 [TBL] [Abstract][Full Text] [Related]
27. Enzyme-resistant CCK analogs with high affinities for central receptors. Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP Peptides; 1988; 9(4):835-41. PubMed ID: 3226959 [TBL] [Abstract][Full Text] [Related]
28. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species. Bianchi BR; Miller TR; Witte DG; Lin CW J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394 [TBL] [Abstract][Full Text] [Related]
29. Feedback inhibition of Ca2+ release by Ca2+ is the underlying mechanism of agonist-evoked intracellular Ca2+ oscillations in pancreatic acinar cells. Zhang BX; Muallem S J Biol Chem; 1992 Dec; 267(34):24387-93. PubMed ID: 1332954 [TBL] [Abstract][Full Text] [Related]
30. Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. Sato S; Stark HA; Martinez J; Beaven MA; Jensen RT; Gardner JD Am J Physiol; 1989 Aug; 257(2 Pt 1):G202-9. PubMed ID: 2475030 [TBL] [Abstract][Full Text] [Related]
31. Role of calcium in cholecystokinin-stimulated phosphoinositide breakdown in exocrine pancreas. Pandol SJ; Thomas MW; Schoeffield MS; Sachs G; Muallem S Am J Physiol; 1985 May; 248(5 Pt 1):G551-60. PubMed ID: 2581457 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors. Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293 [TBL] [Abstract][Full Text] [Related]
33. Regulation of bombesin receptors on pancreatic acini by cholecystokinin. Younes M; Wank SA; Vinayek R; Jensen RT; Gardner JD Am J Physiol; 1989 Feb; 256(2 Pt 1):G291-8. PubMed ID: 2465695 [TBL] [Abstract][Full Text] [Related]
34. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719 [TBL] [Abstract][Full Text] [Related]
35. Modulation of cholecystokinin activity by albumin. Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774 [TBL] [Abstract][Full Text] [Related]
36. Characteristics of pancreatic exocrine secretion produced by venom from the Brazilian scorpion, Tityus serrulatus. Fletcher PL; Fletcher MD; Possani LD Eur J Cell Biol; 1992 Aug; 58(2):259-70. PubMed ID: 1385124 [TBL] [Abstract][Full Text] [Related]
37. 125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides. Fourmy D; Pradayrol L; Vaysse N; Susini C; Ribet A J Immunoassay; 1984; 5(1-2):99-120. PubMed ID: 6201510 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological activity of novel, potent and long-acting analogs of AC-CCK-7 with high affinity for peripheral (type A) receptors. Danho W; Makofske RC; Swistok J; Michalewsky J; Gabriel T; Marks N; Berg MJ; Baird L; Geiler V; Mackie G Pept Res; 1991; 4(2):59-65. PubMed ID: 1815779 [TBL] [Abstract][Full Text] [Related]
39. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues. Tilley JW; Danho W; Lovey K; Wagner R; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S J Med Chem; 1991 Mar; 34(3):1125-36. PubMed ID: 2002454 [TBL] [Abstract][Full Text] [Related]
40. ARL 15849: a selective CCK-A agonist with anorectic activity in the rat and dog. Simmons RD; Kaiser FC; Pierson ME; Rosamond JR Pharmacol Biochem Behav; 1998 Feb; 59(2):439-44. PubMed ID: 9476993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]